Condition | Indicated | Relationship Strength | Studies | Trials |
Cardiac Toxicity [description not available] | 0 | 2.41 | 1 | 0 |
Cardiotoxicity Damage to the HEART or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION. | 0 | 2.41 | 1 | 0 |
Cancer of Colon [description not available] | 0 | 2.21 | 1 | 0 |
Colonic Neoplasms Tumors or cancer of the COLON. | 0 | 2.21 | 1 | 0 |
Canine Diseases [description not available] | 0 | 2.25 | 1 | 0 |
Osteogenic Sarcoma [description not available] | 0 | 2.69 | 2 | 0 |
Animal Mammary Carcinoma [description not available] | 0 | 2.25 | 1 | 0 |
Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) | 0 | 2.69 | 2 | 0 |
Bone Cancer [description not available] | 0 | 2.31 | 1 | 0 |
Experimental Neoplasms [description not available] | 0 | 2.54 | 2 | 0 |
Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. | 0 | 2.31 | 1 | 0 |
Sarcoma, Epithelioid [description not available] | 0 | 10.1 | 8 | 4 |
Sarcoma A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant. | 0 | 10.1 | 8 | 4 |
Metastase [description not available] | 0 | 8.65 | 5 | 4 |
Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. | 0 | 8.65 | 5 | 4 |
Soft Tissue Neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc. | 0 | 3.12 | 1 | 0 |
Benign Neoplasms, Brain [description not available] | 0 | 2.1 | 1 | 0 |
Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 2.1 | 1 | 0 |
Astrocytoma, Grade IV [description not available] | 0 | 2.1 | 1 | 0 |
Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. | 0 | 2.1 | 1 | 0 |
Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. | 0 | 2.1 | 1 | 0 |
Benign Neoplasms [description not available] | 0 | 4.77 | 2 | 1 |
Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. | 0 | 4.77 | 2 | 1 |
Cancer of Ovary [description not available] | 0 | 2.07 | 1 | 0 |
Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. | 0 | 2.07 | 1 | 0 |
Kahler Disease [description not available] | 0 | 2.07 | 1 | 0 |
Angiogenesis, Pathologic [description not available] | 0 | 2.07 | 1 | 0 |
Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. | 0 | 2.07 | 1 | 0 |
Breast Cancer [description not available] | 0 | 2.07 | 1 | 0 |
Breast Neoplasms Tumors or cancer of the human BREAST. | 0 | 2.07 | 1 | 0 |
Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.08 | 1 | 0 |
Cancer of Pancreas [description not available] | 0 | 2.08 | 1 | 0 |
Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). | 0 | 2.08 | 1 | 0 |